Serum glial fibrillary acidic protein and neurofilament light chain as biomarkers of retinal neurodysfunction in early diabetic retinopathy: results of the EUROCONDOR study.

Cristina HernandezOlga Simó-ServatMassimo PortaJakob GrauslundSimon P HardingUlrik Frydkjaer-OlsenJosé García-ArumíLuísa RibeiroPeter ScanlonJosé Cunha-VazRafael Simónull null

Published in: Acta diabetologica (2023)

GFAP could be a useful serum biomarker for retinal neurodysfunction. Monitoring retinal neurodysfunction using blood samples would be of benefit in clinical decision-making. However, further research is needed to validate this result as well as to establish the best cutoff values.

Keyphrases

diabetic retinopathy
optical coherence tomography
decision making
cerebrospinal fluid
ionic liquid
amino acid
binding protein
spinal cord